Our results from the first six months of 2024 are out! In this first half year, we continued to expand the global reach of our life-changing medicines while driving innovation across a growing number of disease areas. Hear our CEO Lars Fruergaard Jørgensen reflect on our performance and learn more here 👉 https://lnkd.in/gu4MH2U #NovoNordisk #DrivingChange
Novo Nordisk
Produktion af lægemidler
Driving change to defeat serious chronic diseases, built upon our heritage in diabetes.
Om os
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 66,000 people in 80 countries and markets its products in around 170 countries. For more information visit novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
- Websted
-
https://www.novonordisk.com
Eksternt link til Novo Nordisk
- Branche
- Produktion af lægemidler
- Virksomhedsstørrelse
- Over 10.001 medarbejdere
- Hovedkvarter
- Bagsværd
- Typ
- Aktieselskab
- Grundlagt
- 1923
- Specialer
- Pharmaceuticals, Insulin, obesity, Rare Diseases og Diabetes
Beliggenheder
Medarbejdere hos Novo Nordisk
-
Thomas Røygaard
PMO | Digital Transformation | Leading Program, Project and Portfolio Management | Governance | Change Management
-
Naras Eechambadi
Global Leader in Data & AI | C-Suite Executive | Board Director | DataIQ Top10 | Executive Coach
-
Sören Meelby
Strategic Alliance Evangelist | Cultivating Partnerships for Collective Impact & Social Good
-
Henrik Vestergaard
Opdateringer
-
Over 12,000 of our colleagues took part in this year’s DHL Relay Run in Denmark! It was amazing to see many wearing rainbow shoelaces to show support for equal opportunities in sports and beyond 🏳️🌈 We are proud to partner with both Stonewall and Pan Idræt to achieve healthy living for all. Read more about the partnerships here: https://lnkd.in/dXNyrK7W. #NovoNordisk #DrivingChange #Inclusion #Health #Allyship
-
Curious to know what our founders did in their spare time? When outside of the lab and office, they enjoyed activities such as gardening, sailing, long walks and not least family time. Check out some of the moments captured 📸 and learn more about our founders here: https://lnkd.in/eC7bD6Ne #NovoNordisk #Founders #History
-
We believe in creating healthier cities for future generations. Through our Cities for Better Health initiative, we are partnering with governments, researchers, and community members in over 45 cities to address the rising prevalence of chronic diseases. By improving access to healthy food and creating more spaces for physical activity, we aim to empower communities to lead healthier lives. What healthy initiatives would you like to see? #NovoNordisk #DrivingChange #HealthyCities
-
Curious to hear the latest scientific conversations by leading experts? 🔬 Access videos, articles, and more at Novo Nordisk CongressHub: https://lnkd.in/dbvSK_tC #NovoNordisk #DrivingChange #Innovation
-
Genetics is one of many factors that play a role in a person’s likelihood of developing obesity. Did you know that the heritability of obesity is as high as 40-70%? Learn more about the multiple factors impacting people living with obesity: https://lnkd.in/eCyWpsQ #NovoNordisk #DrivingChange #Obesity
-
We’re on a mission to drive change for millions of people living with chronic diseases and we need talents to help shape the future. Did you know that we currently have around 1,000 open positions across the world? Check out our career site to see if there is a match for you: https://lnkd.in/dfHdaYP #NovoNordisk #DrivingChange #Career
-
-
It takes more than medicine to defeat chronic diseases. It takes sport, song, culture, collaboration, listening and partnership. Just ask these inspiring people who are making big changes to the health of their communities - each in their own unique way. #NovoNordisk #DrivingChange #Health
-
Missed anything from #ISTH2024? Catch up on the exciting updates from the International Society on #Thrombosis and #Haemostatis at Novo Nordisk CongressHub 👉 https://bit.ly/45rxuxI
-
-
28 June marks the anniversary of the pivotal Stonewall uprising in 1969, which ignited the modern LGBTQ+ rights movement. We have partnered with Stonewall to focus on everyday inclusion for our LGBTQ+ colleagues, fostering an environment where everyone can thrive. To kick off the partnership, we are joining their Rainbow Laces campaign, which aims to spark dialogue around how we can all become active allies for LGBTQ+ inclusion, both in the workplace and in making sport everyone's game. The ask is simple – lace up to speak up! Learn more abut our partnership here: https://lnkd.in/dfT5m4AS
Tilsvarende sider
Aktie
NVO
NYSE
20 minutters forsinkelse
137,55 US$
3,065 (2,279 %)
- Åbningspris
- 136,47
- Lavpunkt
- 135,742
- Højdepunkt
- 137,88
Data fra Refinitiv
Få flere oplysninger påFinansiering
Seneste runde
Post IPO-egenkapital22.000.000,00 US$